LabTurbo Biotech Corporation

TWO:7725 Taiwan Biotechnology
Market Cap
$33.04 Million
NT$1.09 Billion TWD
Market Cap Rank
#45667 Global
#2026 in Taiwan
Share Price
NT$22.80
Change (1 day)
+0.00%
52-Week Range
NT$21.35 - NT$25.70
All Time High
NT$25.70
About

LabTurbo Biotech Corporation engages in the research, manufacture, and sale of gene detection systems and kits in Taiwan, the United States, the Czech Republic, Spain, France, Israel, Singapore, the Philippines, and Malaysia. It serves hospitals. The company was founded in 2000 and is based in Taipei, Taiwan.

LabTurbo Biotech Corporation - Asset Resilience Ratio

Latest as of June 2025: 29.06%

LabTurbo Biotech Corporation (7725) has an Asset Resilience Ratio of 29.06% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
NT$376.51 Million
Cash + Short-term Investments
Total Assets
NT$1.30 Billion
All company assets
Resilience Assessment
Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2022–2024)

This chart shows how LabTurbo Biotech Corporation's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down LabTurbo Biotech Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents NT$0.00 0%
Short-term Investments NT$376.51 Million 29.06%
Total Liquid Assets NT$376.51 Million 29.06%

Asset Resilience Insights

  • Very High Liquidity: LabTurbo Biotech Corporation maintains exceptional liquid asset reserves at 29.06% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

LabTurbo Biotech Corporation Industry Peers by Asset Resilience Ratio

Compare LabTurbo Biotech Corporation's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
MedPacto Inc
KQ:235980
Biotechnology 49.82%
Shenzhen CAU Technology Co Ltd
SHE:000004
Biotechnology 6.20%
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
Biotechnology 6.88%
Nanhua Bio Medicine Co Ltd
SHE:000504
Biotechnology 11.93%
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
Biotechnology 0.03%
Chengzhi Shareholding Co Ltd
SHE:000990
Biotechnology 6.73%
Hualan Biological EngineeringInc
SHE:002007
Biotechnology 14.68%
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030
Biotechnology 4.35%

Annual Asset Resilience Ratio for LabTurbo Biotech Corporation (2022–2024)

The table below shows the annual Asset Resilience Ratio data for LabTurbo Biotech Corporation.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 51.15% NT$710.83 Million NT$1.39 Billion +11.25pp
2023-12-31 39.90% NT$559.30 Million NT$1.40 Billion +17.74pp
2022-12-31 22.16% NT$393.57 Million NT$1.78 Billion --
pp = percentage points